NCT00645593 Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer Status COMPLETED Phase PHASE2
NCT00642174 Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3) Status COMPLETED Phase PHASE2
NCT00642018 A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00641719 A Long-term Study for the Treatment of Painful Diabetic Neuropathy Status COMPLETED Phase PHASE3
NCT00641056 Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3) Status COMPLETED Phase PHASE3
NCT00640510 A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00637273 A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2) Status COMPLETED Phase PHASE3
NCT00636818 Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD) Status COMPLETED Phase PHASE2
NCT00635492 CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy Status COMPLETED Phase N/A
NCT00630825 A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT00630149 Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy Status COMPLETED Phase PHASE2
NCT00627042 Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy Status COMPLETED Phase PHASE2
NCT00623974 Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia Status TERMINATED Phase PHASE2
NCT00623233 Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00622323 Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients Status COMPLETED Phase N/A
NCT00620321 A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia Status COMPLETED Phase PHASE2